Skip to main content
ViewHub
Main Menu
About
Map
Data
Resources
Utility Navigation
Give Feedback
Notice an error? Have more recent data? Use this form to let us know, and help us keep our data accurate and up to date!
Required field
Your Information
Name (Contact Person)
Email address
Country
- Select -
Afghanistan
Albania
Algeria
Andorra
Angola
Antigua and Barbuda
Argentina
Armenia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bhutan
Bolivia (Plurinational State of)
Bosnia and Herzegovina
Botswana
Brazil
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cabo Verde
Cambodia
Cameroon
Canada
Central African Republic
Chad
Chile
China
Colombia
Comoros
Congo
Congo, Democratic Republic of the
Cook Islands
Costa Rica
Côte d'Ivoire
Croatia
Cuba
Cyprus
Czechia
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Eswatini
Ethiopia
Fiji
Finland
France
Gabon
Gambia
Georgia
Germany
Ghana
Greece
Grenada
Guatemala
Guinea
Guinea-Bissau
Guyana
Haiti
Honduras
Hungary
Iceland
India
Indonesia
Iran (Islamic Republic of)
Iraq
Ireland
Israel
Italy
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Korea (Democratic People's Republic of)
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libya
Lithuania
Luxembourg
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Mauritania
Mauritius
Mexico
Micronesia (Federated States of)
Moldova, Republic of
Monaco
Mongolia
Montenegro
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
New Zealand
Nicaragua
Niger
Nigeria
Niue
North Macedonia
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Rwanda
Saint Kitts and Nevis
Saint Lucia
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Sweden
Switzerland
Syrian Arab Republic
Tajikistan
Tanzania, United Republic of
Thailand
Timor-Leste
Togo
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom of Great Britain and Northern Ireland
United States of America
Uruguay
Uzbekistan
Vanuatu
Venezuela (Bolivarian Republic of)
Viet Nam
Yemen
Zambia
Zimbabwe
Where on the site did you find a problem?
Data layer
- None -
Disease Burden - Hib Cases - Number of Cases - Meningitis
Disease Burden - Hib Cases - Number of Cases - NPNM
Disease Burden - Hib Cases - Number of Cases - Pneumonia
Disease Burden - Hib Cases - Number of Cases - Severe Pneumonia
Disease Burden - Hib Cases - Number of Cases - Total
Disease Burden - Hib Deaths - Number of Deaths - Meningitis
Disease Burden - Hib Deaths - Number of Deaths - NPNM
Disease Burden - Hib Deaths - Number of Deaths - Pneumonia
Disease Burden - Hib Deaths - Number of Deaths - Total
Disease Burden - Pneumococcal Cases - Number of Cases - Meningitis
Disease Burden - Pneumococcal Cases - Number of Cases - Non-severe NPNM
Disease Burden - Pneumococcal Cases - Number of Cases - NPNM
Disease Burden - Pneumococcal Cases - Number of Cases - Pneumonia
Disease Burden - Pneumococcal Cases - Number of Cases - Severe Pneumonia
Disease Burden - Pneumococcal Cases - Number of Cases - Total
Disease Burden - Pneumococcal Deaths - Number of Deaths - Meningitis
Disease Burden - Pneumococcal Deaths - Number of Deaths - NPNM
Disease Burden - Pneumococcal Deaths - Number of Deaths - Pneumonia
Disease Burden - Pneumococcal Deaths - Number of Deaths - Total
Economic Burden - Gastroenteritis - Healthcare provider costs: Tests/procedures cost data
Economic Burden - Gastroenteritis - Healthcare provider costs
Economic Burden - Gastroenteritis - Healthcare provider costs: Bed/stay cost data
Economic Burden - Gastroenteritis - Healthcare provider costs: Medications cost data
Economic Burden - Gastroenteritis - Household costs
Economic Burden - Gastroenteritis - Household costs: Indirect cost data
Economic Burden - Gastroenteritis - Household costs: Medical cost data
Economic Burden - Gastroenteritis - Household costs: Non-medical cost data
Economic Burden - Gastroenteritis - Private sector data
Economic Burden - Gastroenteritis - Societal costs
Economic Burden - Gastroenteritis - Type of care provided
Economic Burden - Gastroenteritis - Urban/rural settings
Economic Burden - Meningitis - Healthcare provider costs
Economic Burden - Meningitis - Healthcare provider costs: Bed/stay cost data
Economic Burden - Meningitis - Healthcare provider costs: Medications cost data
Economic Burden - Meningitis - Healthcare provider costs: Tests/procedures cost data
Economic Burden - Meningitis - Household costs
Economic Burden - Meningitis - Household costs: Indirect cost data
Economic Burden - Meningitis - Household costs: Medical cost data
Economic Burden - Meningitis - Household costs: Non-medical cost data
Economic Burden - Meningitis - Private sector data
Economic Burden - Meningitis - Societal costs
Economic Burden - Meningitis - Type of care provided
Economic Burden - Meningitis - Urban/rural settings
Economic Burden - Overview - Number of studies
Economic Burden - Overview - Published Year
Economic Burden - Pneumonia - Healthcare provider costs
Economic Burden - Pneumonia - Healthcare provider costs: Bed/stay cost data
Economic Burden - Pneumonia - Healthcare provider costs: Medications cost data
Economic Burden - Pneumonia - Healthcare provider costs: Tests/procedures cost data
Economic Burden - Pneumonia - Household costs
Economic Burden - Pneumonia - Household costs: Indirect cost data
Economic Burden - Pneumonia - Household costs: Medical cost data
Economic Burden - Pneumonia - Household costs: Non-medical cost data
Economic Burden - Pneumonia - Private sector data
Economic Burden - Pneumonia - Societal costs
Economic Burden - Pneumonia - Type of care provided
Economic Burden - Pneumonia - Urban/rural settings
Hib - Vaccine Access - # Children without Access
Hib - Vaccine Coverage - # Children unvaccinated
Hib - Vaccine Coverage - # Children vaccinated
Hib - Vaccine Coverage - Official country reported coverage
Hib - Vaccine Coverage - WUENIC Coverage rates
Hib - Vaccine Introduction - Current Dosing Schedule
Hib - Vaccine Introduction - Current Program Type
Hib - Vaccine Introduction - Current Vaccine Intro Status
Hib - Vaccine Introduction - Universal vaccine introduction over time
Hib - Vaccine Introduction - Vaccine Product (current/planned)
HPV - Vaccine Introduction - Current Dosing Schedule
HPV - Vaccine Introduction - Current or Planned Distribution Site
HPV - Vaccine Introduction - Current Program Type
HPV - Vaccine Introduction - Current Vaccine Intro Status
HPV - Vaccine Introduction - Target Population - Female or Male
HPV - Vaccine Introduction - Universal vaccine introduction over time
HPV - Vaccine Introduction - Vaccine Product (current/planned)
IPV - Vaccine Access - # Children without Access
IPV - Vaccine Coverage - # Children unvaccinated
IPV - Vaccine Coverage - # Children vaccinated
IPV - Vaccine Coverage - Official country reported coverage
IPV - Vaccine Coverage - WUENIC Coverage rates
IPV - Vaccine Introduction - Current Dosing Schedule
IPV - Vaccine Introduction - Current Program Type
IPV - Vaccine Introduction - Current Vaccine Intro Status
IPV - Vaccine Introduction - IPV-OPV use
IPV - Vaccine Introduction - Universal vaccine introduction over time
IPV - Vaccine Introduction - Vaccine Product (current/planned)
PCV - Availability of Results - Availability of Herd Effect Results
PCV - Availability of Results - Availability of IPD Results
PCV - Availability of Results - Availability of Meningitis Results
PCV - Availability of Results - Availability of Mortality Results
PCV - Availability of Results - Availability of NP carriage Results
PCV - Availability of Results - Availability of NPNM/Sepsis/Bacteremia Results
PCV - Availability of Results - Availability of Pneumonia Results
PCV - Impact Studies - # of Citations
PCV - Impact Studies - Catch-up campaign
PCV - Impact Studies - Countries with impact evaluations
PCV - Impact Studies - Dosing Schedules Evaluated
PCV - Impact Studies - Product evaluated - PCV
PCV - Impact Studies - Study Status
PCV - Impact Studies - Target Population
PCV - Impact Studies - Time Series
PCV - Outcomes - Herd effect
PCV - Outcomes - IPD
PCV - Outcomes - Meningitis
PCV - Outcomes - Mortality
PCV - Outcomes - NP carriage
PCV - Outcomes - NPNM/Sepsis/Bacteremia
PCV - Outcomes - Pneumonia
PCV - Vaccine Access - Children without access
PCV - Vaccine Coverage - # Children unvaccinated
PCV - Vaccine Coverage - # Children vaccinated
PCV - Vaccine Coverage - Official country reported coverage
PCV - Vaccine Coverage - WUENIC Coverage
PCV - Vaccine Introduction - Current Dosing Schedule
PCV - Vaccine Introduction - Current Program Type
PCV - Vaccine Introduction - Current Vaccine Intro Status
PCV - Vaccine Introduction - Universal vaccine introduction over time
PCV - Vaccine Introduction - Vaccine Product (current/planned)
Program Costing - Delivery Cost - AEFI and disease surveillance
Program Costing - Delivery Cost - Buildings, utilities, other overheads and/or shared costs
Program Costing - Delivery Cost - Cold chain equipment and their overheads (installation, energy, maintenance, repairs)
Program Costing - Delivery Cost - IEC/social mobilization and advocacy
Program Costing - Delivery Cost - Other
Program Costing - Delivery Cost - Other supplies and recurrent costs
Program Costing - Delivery Cost - Per diem and travel allowances
Program Costing - Delivery Cost - Personnel (paid human resources)
Program Costing - Delivery Cost - Program management
Program Costing - Delivery Cost - Shared Personnel costs
Program Costing - Delivery Cost - Shared transportation costs
Program Costing - Delivery Cost - Training and capacity building
Program Costing - Delivery Cost - Vehicles, transport and fuel
Program Costing - Delivery Cost - Volunteer human resources
Program Costing - Delivery Cost - Waste management
Program Costing - Economic perspective - External donor perspective
Program Costing - Economic perspective - Government perspective
Program Costing - Economic perspective - Healthcare provider perspective
Program Costing - Economic perspective - Societal perspective
Program Costing - Overview - Costing approach
Program Costing - Overview - Economic perspectives
Program Costing - Overview - Entire EPI schedule
Program Costing - Overview - Full or incremental costing
Program Costing - Overview - Immunization Delivery Cost (Completion Scale)
Program Costing - Overview - Number of studies
Program Costing - Overview - Publication year/baseline year
Program Costing - Overview - Routine vs. SIA
Program Costing - Overview - Vaccine Cost (Completion Scale)
Program Costing - Vaccine Cost - Buffer stock rate
Program Costing - Vaccine Cost - Injection supplies and freight
Program Costing - Vaccine Cost - Wastage Rate
Program Costing - Vaccines evaluated - All vaccines in the national immunization schedule
Program Costing - Vaccines evaluated - BCG
Program Costing - Vaccines evaluated - Cholera vaccine
Program Costing - Vaccines evaluated - DT
Program Costing - Vaccines evaluated - HepB
Program Costing - Vaccines evaluated - HPV
Program Costing - Vaccines evaluated - IPV
Program Costing - Vaccines evaluated - JE
Program Costing - Vaccines evaluated - Measles
Program Costing - Vaccines evaluated - Meningococcal
Program Costing - Vaccines evaluated - MMR
Program Costing - Vaccines evaluated - OCV
Program Costing - Vaccines evaluated - OPV
Program Costing - Vaccines evaluated - PCV
Program Costing - Vaccines evaluated - Rotavirus
Program Costing - Vaccines evaluated - VitA
Program Costing - Vaccines evaluated - YF
RV - Availability of Results - Availability of All-Cause Diarrhea/Gastroenteritis Results
RV - Availability of Results - Availability of Herd Effect Results
RV - Availability of Results - Availability of Intussusception Results
RV - Availability of Results - Availability of Mortality Results
RV - Availability of Results - Availability of Rotavirus Diarrhea Results
RV - Availability of Results - Availability of Rotavirus Infection in Community Results
RV - Availability of Results - Availability of Rotavirus Strains (Genetic diversity) Results
RV - Availability of Results - Availability of Seizure Results
RV - Impact Studies - # of Citations
RV - Impact Studies - Countries with impact evaluations
RV - Impact Studies - Dosing Schedules Evaluated
RV - Impact Studies - Product evaluated-RV
RV - Impact Studies - Study Status
RV - Impact Studies - Target Population
RV - Impact Studies - Time Series
RV - Impact Studies - Vaccine Effectiveness
RV - Outcomes - All-cause diarrhea/gastroenteritis
RV - Outcomes - Herd effect
RV - Outcomes - Intussusception
RV - Outcomes - Mortality
RV - Outcomes - Rotavirus diarrhea
RV - Outcomes - Rotavirus infection in community
RV - Outcomes - Rotavirus Strains (Genetic diversity)
RV - Outcomes - Seizures
RV - Vaccine Access - # Children without Access
RV - Vaccine Coverage - # Children unvaccinated
RV - Vaccine Coverage - # Children vaccinated
RV - Vaccine Coverage - Official country reported coverage
RV - Vaccine Coverage - WUENIC Coverage
RV - Vaccine Introduction - Current Dosing Schedule
RV - Vaccine Introduction - Current Program Type
RV - Vaccine Introduction - Current Vaccine Intro Status
RV - Vaccine Introduction - Universal vaccine introduction over time
RV - Vaccine Introduction - Vaccine Product (current/planned)
Describe the issue